Spire Healthcare Group PLC
LSE:SPI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/GP
Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.
Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.
Valuation Scenarios
If EV/GP returns to its 3-Year Average (3.1), the stock would be worth GBX198.16 (23% upside from current price).
| Scenario | EV/GP Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 2.5 | GBX161 |
0%
|
| 3-Year Average | 3.1 | GBX198.16 |
+23%
|
| 5-Year Average | 3.3 | GBX207.9 |
+29%
|
| Industry Average | 0 | GBX0.57 |
-100%
|
| Country Average | 0 | GBX0.6 |
-100%
|
Forward EV/GP
Today’s price vs future gross profit
Peer Comparison
| Market Cap | EV/GP | P/E | ||||
|---|---|---|---|---|---|---|
| UK |
|
Spire Healthcare Group PLC
LSE:SPI
|
648.4m GBP | 2.5 | 39.5 | |
| US |
|
HCA Healthcare Inc
NYSE:HCA
|
97.2B USD | 2.1 | 14.3 | |
| SA |
|
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
98B SAR | 24.9 | 40.8 | |
| ZA |
N
|
Netcare Ltd
JSE:NTC
|
23.4B ZAR | 2.5 | 13.9 | |
| MY |
I
|
IHH Healthcare Bhd
KLSE:IHH
|
77.8B MYR | 4.8 | 37.1 | |
| ZA |
L
|
Life Healthcare Group Holdings Ltd
JSE:LHC
|
17.6B ZAR | 2.1 | 4.5 | |
| BR |
|
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
|
83.3B BRL | 7.4 | 17.8 | |
| US |
|
Tenet Healthcare Corp
NYSE:THC
|
15.7B USD | 1.5 | 11.2 | |
| CN |
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
102.1B CNY | 9.7 | 30.3 | |
| IN |
|
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
|
1.1T INR | 9.7 | 60.6 | |
| US |
|
Ensign Group Inc
NASDAQ:ENSG
|
10.8B USD | 9.6 | 31.1 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0 |
| Median | 0 |
| 70th Percentile | 0 |
| Max | 664.3 |
Other Multiples
Spire Healthcare Group PLC
Glance View
Spire Healthcare Group PLC, a notable player in the UK’s independent hospital sector, operates an extensive network of private hospitals and clinics. Born out of Bupa’s acute care business in 2007, the company has carved a niche by offering a wide array of medical services, including elective surgeries, diagnostic tests, and specialist consultations. Spire’s revenue model revolves around providing these healthcare services both to self-paying patients and those insured with private medical insurance. A considerable portion of its income is also derived from contracts with the National Health Service (NHS), where Spire steps in to help reduce the public healthcare system’s waiting times. This dual-source revenue model allows Spire to balance its operations among private and public healthcare sectors effectively. The company's operations are anchored in a commitment to quality care, which is pivotal in sustaining its reputation and patient trust. Each healthcare facility is equipped with cutting-edge medical technology and staffed by experienced healthcare professionals, ensuring high standards of treatment and customer service. Spire’s strategic focus on investing in medical infrastructure and skilled personnel enables it to deliver specialized services that attract a broad demographic, from routine procedures to complex surgeries. As the healthcare landscape evolves, Spire Healthcare continues to adapt, striving to expand its service offerings and affordable healthcare solutions, whilst ensuring its hospitals and clinics remain synonymous with clinical excellence and patient satisfaction. This strategy appears designed not just to maintain its market position, but to meet the increasing demand for diverse and comprehensive healthcare services in the UK.